The influence of external factors on the development of olfactory disorders in patients with the coronavirus disease 2019: an immunomorphological assessment

Authors

DOI:

https://doi.org/10.26641/2307-0404.2024.1.300438

Keywords:

odorants, olfaction, olfactory epithelium, coronavirus disease 2019 (COVID-19), coronavirus infection, SARS-CoV-2

Abstract

Olfactory disorders of various etiology are an actual problem for a large part of the adult population of the world, according to the results of conducted research, their prevalence is about 19%. Hyposmia, anosmia, or dysosmia are considered the initial symptom in more than 25% of patients, but over time they affect more than 75% of the total number of patients. The main risk factors for the development of olfactory disorders are old age, male gender, head injuries, exposure to toxic substances and infectious diseases of the upper respiratory tract. The purpose of the study is to clarify the immunomorphological features of the olfactory epithelium of the nasal cavity of patients with the 2019 coronavirus disease, taking into account the background pathological changes in the structures of this area for a better understanding of the mechanisms of the development of olfactory dysfunction during infection with the SARS-CoV-2 coronavirus, depending on the presence of aggravating factors. Autopsy material was used for the study, namely fragments of the mucous membrane of the upper parts of the nasal cavity (olfactory epithelium), obtained from 20 deceased (8 women and 12 men) aged 53 to 86 years with a diagnosis of "Coronavirus disease 2019", confirmed by laboratory (polymerase chain reaction) and olfactory disorders of various degrees in the anamnesis. Mucosal samples were stained with standard hematoxylin and eosin and using an immunohistochemical method with antibodies to neuron-specific beta-III tubulin (TuJ-1), olfactory marker protein (OMP) and angiotensin-converting enzyme (ACE-2). The distribution of expression variants of receptors to OMP, TuJ-1 and ACE-2 in sections with signs of structural rearrangement and without signs of structural rearrangement at a magnification of 200x showed a significant difference (p<0.05): the number of OMP-positive cells in sections of the olfactory epithelium of the first group on average was 43.5 in the field of view (16.0-59.0), TuJ-1-positive cells in these sections – 44.5 in the field of view (17.0-61.0), ACE-2-positive cells – 37 in the field of view (14.0-55.0), and in the samples of the olfactory epithelium of the second group, the expression of receptors to OMP was only partially positive (18 (12.0-25.0) cells), TuJ-1 – 17.5 (14.0-24.0) cells, ACE-2 – 14 (9.0-18.0) cells. That is, the occurrence of olfactory disorders under the conditions of infection with the SARS-CoV-2 coronavirus can be both de novo and against the background of previous changes in the structural elements of the olfactory area of the mucous membrane of the nasal cavity. In this case, more vivid symptoms are likely, as well as criticality and irreversibility of pathological changes.

References

Ajmani GS, Suh HH, Wroblewski KE, et al. Smoking and Olfactory Dysfunction: a Systematic Literature Review and Meta-Analysis. Laryngoscope. 2017;127:1753-61. doi: https://doi.org/10.1002/lary.26558

Williams FMK, Freidin MB, Mangino M, et al. Self-reported symptoms of COVID-19 including symptoms most predictive of SARS-CoV2 infection, are heritable. Med Rxiv preprint. 2020;23:316-21. doi: https://doi.org/10.1101/2020.04.22.20072124

Palmquist E, Larsson M, Olofsson JK, et al. A Pros¬pective Study on Risk Factors for Olfactory Dys-function in Aging. J Gerontol A Biol Sci Med Sci. 2020;75:603-10. doi: https://doi.org/10.1093/gerona/glz265

Tong JY, Wong A, Zhu D, et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and metaanalysis. Otolaryngol Head Neck Surg. 2020;163:3-11. doi: https://doi.org/10.1177/0194599820926473

Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020;20:1015-6. doi: https://doi.org/10.1016/S1473-3099(20)30293-0

Yan CH, Faraji F, Prajapati DP, et al. Self-re-ported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. 2020;10:821-31. doi: https://doi.org/10.1002/alr.22592

Mosaad AA, Noha A. Dysosmia in Recovered COVID-19 Patients. J Craniofac Surg. 2023;34:843-4. doi: https://doi.org/10.1097/SCS.0000000000009008

Vaira LA, Salzano G, Fois AG, et al. Potential pathogenesis of ageusia and anosmia in COVID-19 pa-tients. Int Forum Allergy Rhinol. 2020;10:1103-4. doi: https://doi.org/10.1002/alr.22593

Bilinska K, Jakubowska P, Von Bartheld C, et al. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identi-fication of Cell Types and Trends with Age. ACS Chemical Neuroscience. 2020;11:1555-62. doi: https://doi.org/10.1021/acschemneuro.0c00210

Chen CR, Kachramanoglou C, Li D, et al. Ana-tomy and Cellular Constituents of the Human Olfactory Mucosa: A Review. J Neurol Surg B Skull Base. 2014;75:293-300. doi: https://doi.org/10.1055/s-0033-1361837

Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of cent¬ral nervous system entry in individuals with COVID-19. Nature Neuroscience. 2021;24:168-75. doi: https://doi.org/10.1038/s41593-020-00758-5

Butowt R, Von Bartheld C. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. The Neuroscientist. 2021;27:582-603. doi: https://doi.org/10.1177%2F1073858420956905

Goncalves S, Goldstein BJ. Pathophysiology of Olfactory Disorders and Potential Treatment Strategies. Curr Otorhinolaryngol Rep. 2016;4:115-21. doi: https://doi.org/10.1007/s40136-016-0113-5

Saussez S, Lechien JR, Hopkins C. Anosmia: an evo¬lution of our understanding of its importance in COVID‑19 and what questions remain to be answered. European Archives of Oto-Rhino-Laryngology. 2021;278:2187-91. doi: https://doi.org/10.1007/s00405-020-06285-0

Van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a short cut for influenza and other viral diseases into the central nervous system. J Pathol. 2015;235:277-87. doi: https://doi.org/10.1002/path.4461

Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12:8. doi: https://doi.org/10.1038/s41368-020-0074-x

Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016-35. doi: https://doi.org/10.1016/j.cell.2020.04.035

Zubair AS, McAlpine LS, Gardin T, et al. Neuro-pathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77:1018-27. doi: https://doi.org/10.1001/jamaneurol.2020.2065

Werner S, Nies E. Olfactory dysfunction revisited: a reappraisal of work-related olfactory dysfunction caused by chemicals. Journal of Occupational Medicine and Toxicology. 2018;13:28. doi: https://doi.org/10.1186/s12995-018-0209-6

Strahova OP, Androsov OI. [Statistical methods of processing the results of medical and biological research]. Lviv; 2021. 164 p. Ukrainian.

Published

2024-04-01

How to Cite

1.
Shponka I, Usova O. The influence of external factors on the development of olfactory disorders in patients with the coronavirus disease 2019: an immunomorphological assessment. Med. perspekt. [Internet]. 2024Apr.1 [cited 2024Nov.29];29(1):4-9. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/300438

Issue

Section

THEORETICAL MEDICINE